Natco-Pharma - Latest News on Natco-Pharma | Read Breaking News on Zee News

The Compulsions and Repercussions of Compulsory Licensing

Last Updated: Friday, October 12, 2012, 17:39

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.

The Compulsions and Repercussions of Compulsory Licensing

Last Updated: Sunday, September 02, 2012, 17:23

The recent erosion of investor confidence in India that is doing the rounds in corporate circles is due to a variety of self-defeating strategies that have been adopted by the government.

Natco Pharma Q1 net up 21.66% at Rs 17 cr

Last Updated: Saturday, August 11, 2012, 21:00

The company had posted a net profit of Rs 14.03 crore for the corresponding quarter previous fiscal, Natco Pharma said in a filing to BSE.

Bayer challenges Nexavar generic licence order

Last Updated: Monday, May 07, 2012, 19:56

Drugmaker Bayer has filed an appeal against an Indian Patents Office's order, which allowed domestic drug maker Natco Pharma to sell a generic version of the German firm's cancer drug 'Nexavar' in India, with the Intellectual Property Appellate Board.

Govt lets sale of cancer drug cheaper by 30 times

Last Updated: Wednesday, March 14, 2012, 00:27

In a first, India on Tuesday invoked a law permitting Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar at a price, over 30 times lower than charged by its patent-holder Bayer Corporation.

Govt lets sale of cancer drug cheaper by 30 times

Last Updated: Tuesday, March 13, 2012, 09:07

In a first, India on Tuesday invoked a law permitting Hyderabad-based Natco Pharma to manufacture and sell cancer-treatment drug Nexavar at a price, over 30 times lower than charged by its patent-holder Bayer Corporation.

Sun Pharma's Dilip Shanghvi buys 3.5% stake in Natco Pharma

Last Updated: Thursday, December 08, 2011, 19:47

Sun Pharma's chief Dilip S Shanghvi has bought 10 lakh shares or about 3.5 percent stake in the drugmaker's smaller rival Natco Pharma for an estimated Rs 25 crore.